Pristiq vs. Fluoxetine

See how Pristiq and Fluoxetine compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Pristiq is an SNRI with a single maintenance dose, while fluoxetine is an SSRI that offers more flexible dosing, including a once-weekly option.

  • Fluoxetine covers a much broader range of FDA-approved uses, including OCD, bulimia, and pediatric depression, while Pristiq is approved only for adult MDD.

  • Both carry a boxed warning for suicidal thinking in young people and should never be combined with MAOIs due to serotonin syndrome risk.

Pristiq vs. Fluoxetine Drug Summary

Pristiq

Pristiq (desvenlafaxine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved to treat major depressive disorder in adults. It comes as an extended-release tablet taken once daily, with 50 mg serving as both the starting and maintenance dose.

Fluoxetine

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder, OCD, bulimia nervosa, panic disorder, and certain bipolar depression regimens. It is taken once daily, starting at a lower dose and increasing over time, with an option for once-weekly maintenance dosing.

Pristiq vs. Fluoxetine Side Effects

Pristiq

Most common
nausea (up to 41%)
dry mouth (up to 25%)
dizziness (up to 16%)
constipation (up to 14%)

Fluoxetine

Most common
insomnia (up to 33%)
nausea (up to 21%)
headache (up to 21%)
somnolence (up to 13%)

Pristiq vs. Fluoxetine Dosage

Pristiq

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 50 mg once daily Day 1 onward
Maximum dose 50 mg once daily Same as starting
Dose changes None Fixed dose

Fluoxetine

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily Week 1
Maximum dose 20 mg once daily Week 2 onward
Dose changes 1 increase Every week

Pristiq vs. Fluoxetine Indications

Pristiq

Pristiq is FDA-approved solely for treating major depressive disorder in adults. It is not approved for pediatric use and requires dosage adjustments in patients with severe kidney impairment.

  • FDA-approved for major depressive disorder (MDD) in adults

  • Not approved for use in children or adolescents

  • Not approved for use without adjustment in severe kidney disease

Fluoxetine

Fluoxetine is approved for a wider range of conditions, including OCD, bulimia nervosa, panic disorder, and bipolar depression with olanzapine. It's also approved for children and teens with depression or OCD.

  • FDA-approved for major depressive disorder in adults and children 8-18

  • Approved for OCD in adults and children 7-17

  • Approved for bulimia nervosa and panic disorder in adults

Pristiq vs. Fluoxetine Pros and Cons

Pristiq

Pristiq's single 50 mg dose works as both the starting and long-term dose, which simplifies treatment for some patients. Its narrower FDA approval and higher price compared to older generics are real trade-offs to weigh.

Pros

  • Single 50 mg dose serves as both starting and maintenance therapy

  • SNRI action on norepinephrine may help when SSRIs alone haven't worked

  • Not metabolized through CYP2D6, avoiding that interaction pathway

  • Generic desvenlafaxine available for lower-cost alternative to brand

Cons

  • Only FDA-approved for adults with major depressive disorder

  • Higher rates of dry mouth, hyperhidrosis, and constipation than SSRIs

  • Typically costs more, roughly $400 to $543 per month before insurance

  • No pediatric or off-label indications established in FDA labeling

Fluoxetine

Fluoxetine's decades of use and broad approval list make it a versatile option across several psychiatric conditions. Its low generic cost is a major advantage, though reaching a therapeutic dose takes more titration steps than Pristiq.

Pros

  • Approved for a wide range of conditions, from OCD to bulimia to panic

  • Available as capsule, tablet, or oral solution for flexible use

  • Decades of generic availability keep costs low, roughly $25 to $60 per month

  • Once-weekly maintenance dosing option available for some patients

Cons

  • Requires titration across several dose steps to reach a therapeutic level

  • Long-acting metabolite can prolong drug interactions after stopping

  • Contraindicated with pimozide and thioridazine due to QT prolongation risk

  • Insomnia is more common than with Pristiq

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.